As a guest user you are not logged in or recognized by your IP address. You have
access to the Front Matter, Abstracts, Author Index, Subject Index and the full
text of Open Access publications.
Cognitive impairment is a serious condition which requires specific medication. Cognitive enhancers may target several categorical indications. Cognitive enhancement need to be specific to the condition inducing cognitive impairment. There are no formal guidelines for drug development regarding cognitive impairment. A clear regulatory road map is therefore required to guide clinical trials aiming at development of new drugs improving cognition.
This website uses cookies
We use cookies to provide you with the best possible experience. They also allow us to analyze user behavior in order to constantly improve the website for you. Info about the privacy policy of IOS Press.
This website uses cookies
We use cookies to provide you with the best possible experience. They also allow us to analyze user behavior in order to constantly improve the website for you. Info about the privacy policy of IOS Press.
loading subjects...
